Previous research has indicated that sex steroid hormones and their receptor signaling pathways in breast cancer cells influence the tumor microenvironment, and that hormone receptor expression status is closely associated with the diversity of the immune cell profile [13]. This evidence concerns the gene NR4A1 and neoplasm.